Symrise and Cutech have jointly developed an ex vivo real skin model that provides conclusive information on the efficacy of, for example, anti-aging products. The model bridges the gap between in vitro and in vivo testing, according to the companies. Symrise and Cutech have now received a European patent for the method. The requirements and the economic parameters involved in the development and marketing of new products are continually growing and changing. Thus, it is of pivotal importanc...